Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | -5.14% | -7.78% | +193.81% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+193.81% | 305M | |
+38.69% | 728B | |
+32.83% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.75% | 244B | |
+7.95% | 207B | |
-5.32% | 205B | |
+6.42% | 164B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Insider Trends: Insider 90-Day Selling Trend Extended at Nektar Therapeutics